NASDAQ:COLL
$28.29
(
-0.632%
)
Friday, 27th Jan 2023
Collegium Pharmaceutical Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $22.55 | $30.22 | Friday, 27th Jan 2023 COLL stock ended at $28.29. This is 0.632% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 3.06% from a day low at $27.75 to a day high of $28.60. |
| 90 days | $16.86 | $30.22 | |
| 52 weeks | $14.04 | $30.22 |
Historical Collegium Pharmaceutical prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $28.43 | $28.60 | $27.75 | $28.29 | 134 868 |
| 2023-01-26 | $28.83 | $30.22 | $27.89 | $28.47 | 283 800 |
| 2023-01-25 | $28.32 | $28.61 | $27.75 | $28.58 | 138 203 |
| 2023-01-24 | $28.23 | $29.04 | $27.43 | $28.58 | 569 273 |
| 2023-01-23 | $28.00 | $28.70 | $27.03 | $28.23 | 506 133 |
| 2023-01-20 | $28.25 | $28.25 | $27.38 | $27.57 | 206 600 |
| 2023-01-19 | $28.32 | $28.33 | $26.72 | $27.98 | 291 400 |
| 2023-01-18 | $28.35 | $28.98 | $27.81 | $28.25 | 474 734 |
| 2023-01-17 | $28.44 | $28.99 | $27.72 | $28.39 | 178 311 |
| 2023-01-13 | $28.59 | $29.02 | $28.35 | $28.73 | 471 311 |
| 2023-01-12 | $27.39 | $28.88 | $27.18 | $28.74 | 292 415 |
| 2023-01-11 | $28.35 | $28.67 | $27.07 | $27.38 | 260 729 |
| 2023-01-10 | $28.26 | $28.69 | $27.72 | $28.45 | 543 900 |
| 2023-01-09 | $28.81 | $28.81 | $26.43 | $27.91 | 807 400 |
| 2023-01-06 | $28.10 | $29.78 | $28.00 | $28.65 | 1 019 200 |
| 2023-01-05 | $27.10 | $28.12 | $26.91 | $28.04 | 1 150 910 |
| 2023-01-04 | $24.04 | $27.08 | $23.72 | $26.98 | 1 168 651 |
| 2023-01-03 | $23.36 | $23.68 | $22.72 | $23.58 | 295 157 |
| 2022-12-30 | $23.08 | $23.30 | $22.55 | $23.20 | 148 712 |
| 2022-12-29 | $23.60 | $23.73 | $23.04 | $23.09 | 156 818 |
| 2022-12-28 | $23.43 | $23.95 | $23.18 | $23.37 | 117 682 |
| 2022-12-27 | $23.01 | $24.36 | $22.68 | $23.55 | 242 177 |
| 2022-12-23 | $23.11 | $23.11 | $22.71 | $22.96 | 106 572 |
| 2022-12-22 | $22.79 | $23.00 | $22.55 | $22.97 | 104 135 |
| 2022-12-21 | $22.87 | $23.40 | $22.87 | $23.00 | 221 741 |
| 2022-12-20 | $22.79 | $23.34 | $22.79 | $22.86 | 283 328 |
| 2022-12-19 | $22.72 | $23.13 | $22.46 | $22.78 | 274 080 |
| 2022-12-16 | $22.29 | $22.79 | $22.10 | $22.75 | 928 551 |
| 2022-12-15 | $22.47 | $22.64 | $22.26 | $22.49 | 199 787 |
| 2022-12-14 | $22.19 | $22.93 | $21.95 | $22.67 | 197 541 |
| 2022-12-13 | $22.21 | $22.50 | $21.93 | $22.09 | 448 580 |
| 2022-12-12 | $21.97 | $22.10 | $21.57 | $21.85 | 174 701 |
| 2022-12-09 | $22.50 | $22.50 | $21.77 | $21.89 | 127 441 |
| 2022-12-08 | $21.96 | $22.79 | $21.78 | $22.50 | 139 794 |
| 2022-12-07 | $22.39 | $22.75 | $21.87 | $21.87 | 144 593 |
| 2022-12-06 | $22.48 | $22.65 | $22.12 | $22.40 | 225 246 |
| 2022-12-05 | $22.99 | $22.99 | $22.27 | $22.73 | 205 571 |
| 2022-12-02 | $22.55 | $23.27 | $22.36 | $23.02 | 284 311 |
| 2022-12-01 | $21.88 | $22.98 | $21.85 | $22.88 | 415 181 |
| 2022-11-30 | $21.24 | $21.94 | $21.05 | $21.87 | 203 177 |
| 2022-11-29 | $21.40 | $21.65 | $21.21 | $21.25 | 98 280 |
| 2022-11-28 | $21.52 | $21.99 | $21.24 | $21.45 | 133 170 |
| 2022-11-25 | $21.51 | $21.98 | $21.34 | $21.66 | 102 764 |
| 2022-11-23 | $21.85 | $21.99 | $21.36 | $21.49 | 93 072 |
| 2022-11-22 | $21.80 | $21.99 | $21.25 | $21.94 | 171 614 |
| 2022-11-21 | $21.70 | $21.97 | $21.43 | $21.59 | 131 730 |
| 2022-11-18 | $21.80 | $22.09 | $21.20 | $21.93 | 249 182 |
| 2022-11-17 | $20.89 | $21.34 | $20.80 | $21.24 | 130 461 |
| 2022-11-16 | $21.55 | $21.65 | $20.62 | $20.74 | 164 278 |
| 2022-11-15 | $20.18 | $21.66 | $20.08 | $21.50 | 262 893 |
About Collegium Pharmaceutical
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
